2025 Annual Report of Journal of Translational Genetics and Genomics

The year 2025 marked an important stage in the ongoing development of Journal of Translational Genetics and Genomics (JTGG; ISSN 2578-5281). Throughout the year, the journal remained committed to its mission of publishing rigorous, peer-reviewed research that advances the translation of discoveries in genetics and genomics into clinical and healthcare applications. By enhancing editorial standards, expanding international participation, and promoting academic exchange, JTGG has continued to establish itself as a reliable young international open access journal.

Message from the Editor-in-Chief

It is my great pleasure to share that Journal of Translational Genetics and Genomics has officially received its first Impact Factor of 1.0 in the Journal Citation Reports™ (Clarivate). This marks an important milestone for a relatively new journal that has been steadily building its reputation in the field of genetics and genomics. Despite its short history, the journal has worked tirelessly to establish itself as a credible platform for advancing scientific knowledge through high-quality research publications, carefully curated Special Issues, thought-provoking webinars, and dynamic academic discussions. Achieving this Impact Factor reflects both the journal's commitment to excellence and the growing recognition of its contributions within the scientific community.

As we continue to grow, I strongly encourage researchers and scientists working in genetics, genomics, and related fields to consider submitting their work to JTGG. By doing so, you not only gain an opportunity to showcase your research on a global platform but also contribute to shaping a resource that actively drives innovation, informs healthcare practice, and advances the broader scientific and societal impact of translational genomics. Together, we can build on this momentum and strengthen the role of the journal as an active platform for scientific exchange and collaboration.

Thank you to all Editorial Board members, authors, reviewers, readers, and editorial staff for your invaluable support.
Prof. Sanjay Gupta
Editor-in-Chief

1.Indexing and Metrics

In November 2025, JTGG was indexed in the Asian Science Citation Index (ASCI). The journal is also included in several recognized databases and platforms, including the Emerging Sources Citation Index (ESCI), Scopus, Chemical Abstracts Service (CAS), Dimensions, and China National Knowledge Infrastructure (CNKI). High-quality indexing goes beyond visibility; it also holds credibility and trust.

Figure 1. JTGG Indexed in ASCI

JTGG received its first Impact Factor of 1.0, ranking in Q4 in the Genetics & Heredity category

Figure 2. JTGG First Impact Factor (1.0)

JTGG's 2024 CiteScore (Scopus) reached 2.0, with the 2025 CiteScoreTracker rising to 2.5.

Figure 3. JTGG CiteScore 2024 and 2025 Tracker

2. Submissions and Publications

In 2025, JTGG received 173 submissions from 674 authors and published 30 articles, corresponding to a rejection rate of 83.75%. Compared with 2024, submissions increased by 31.06% and publications by 11.1%, demonstrating growing author interest while maintaining rigorous peer-review standards.

The 30 articles published in 2025 involved 163 contributing authors, representing a 42.9% increase over 2023 and indicating steady growthandbroader international engagement. JTGG continues to publish a diverse range of article types, with Original Research Articles accountingfor 46.7% of total publications. Increasing the proportion of original research remains a strategic priority to reinforce the journal's role as a platform for high-quality, cutting-edge studies in translational genetics and genomics.

3. Readership and Citations

JTGG experienced continued growth in article views and downloads, reflecting increasing visibility and engagement fromthe international research community.

Figure 4. JTGG Article Views by Country and Data in the Last 6 Months of 2025

Figure 5. JTGG Article Downloads by Country and Data in the Last 6 Months of 2025

In 2025, JTGG articles received 217 citations from authors in 25 countries and regions, according to data from Web of Science. The five countries contributing the highest number of citations were the USA, China, Germany, Italy, and Japan.

Figure 6. Citations by Country/Region

Analysis of citing journals shows that a substantial proportion of citations came from Q1 and Q2 journals, indicating that JTGG publications arerecognized by well-established journals in related fields.

Figure 7. Quartile Distribution of Citing Journals

Table 1. Citing Journals of JTGG in 2025 (Q1)

4. Special Issues

In 2025, JTGG launched 12 Special Issues, of which 3 were completed during the year. These thematic collections highlight the journal'sengagement with emerging and specialized research areas.

Figure 8. Covers of Special Issues in 2025

A total of 37 manuscripts were submitted to Special Issues in 2025. Of the 30 articles published during the year, 18 originated from these collections, underscoring the important role of Special Issues in shaping the journal's thematic focus and attracting targeted scholarlycontributions.

5. Editorial Board Updates

In 2025, JTGG further strengthened its editorial team with the appointment of 18 new Editorial Board Members and 21 Junior Editorial Board Members from institutions across Asia, Europe, and North America. Their expertise strengthens the journal's peer-review capacity, broadens its subject coverage, and reinforces its global perspective.

Table 2. Editorial Board Members Appointed in 2025

Photo	Name	Institution
	Bing Yao	Emory University School of Medicine, Atlanta, GA, USA
	Junjiang Fu	Southwest Medical University, Luzhou, Sichuan, China
	Yifang Ping	Third Military Medical University, Chongqing, China
	Lei Song	The First Affiliated Hospital of Jilin University, Changchun, Jilin, China
	Houfeng Zheng	The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
	Zhu Chen	University of South China, Hengyang, Hunan, China
	Liming Bao	Weill Cornell Medicine, New York, NY, USA
	Harry Steinbusch	Maastricht University, Maastricht, the Netherlands
	Xiaoyang Zhao	Southern Medical University, Guangzhou, China
	Jinrong Min	Central China Normal University, Wuhan, Hubei, China
	Joanne Ngeow Yuen Yie	Nanyang Technological University, Singapore
	Ni-Chung Lee	National Taiwan University Hospital, Taipei, Taiwan, China
	Chengtao Li	Fudan University, Shanghai, China
	Xi Luo	Baylor College of Medicine, Houston, TX, USA.
	Jiangwei Yan	Shanxi Medical University, Jinzhong, Shanxi, China
	Ting Wen	Henry Ford Health System, Detroit, Michigan, USA
	Ying S. Zou	Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
	Taosheng Huang	Fudan University, Shanghai, China

Table 3. Junior Editorial Board Members Appointed in 2025

Photo	Name	Institution
	Dong He	Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China
	Lakshya Bajaj	University of Puerto Rico, San Juan, PR, USA
	Weijing Gong	Huazhong University of Science and Technology, Wuhan, Hubei, China
	Baolin Guo	Fourth Military Medical University, Xi'an, Shaanxi, China
	Long Guo	Xi'an Jiaotong University, Xi'an, Shaanxi, China
	Fei Guo	Shenyang Medical College, Shenyang, Liaoning, China
	Chengqi Lin	Southeast University, Nanjing, Jiangsu, China
	Chuxiao Liu	Chinese Academy of Sciences, Shanghai, China
	Duanrui Liu	Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China
	Songqiao Liu	Southeast University, Nanjing, Jiangsu, China
	Lingbin Meng	The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA
	Shitao Rao	Fujian Medical University, Fuzhou, Fujian, China
	Haijian Sun	The Second Qilu Hospital of Shandong University, Jinan, Shandong, China
	Jia Tang	Guangdong Provincial Fertility Hospital, Guangzhou, Guangdong, China
	Mengge Wang	Chongqing Medical University, Chongqing, China
	Bo Xiong	Huazhong University of Science and Technology, Wuhan, Hubei, China
	Guohua Yang	Wuhan University, Wuhan, Hubei, China
	Jun Yao	China Medical University, Beijing, China
	Yaxing Zhang	Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China
	Xingwang Zhou	Guizhou Medical University, Guiyang, Guizhou, China
	Fusheng Zhou	The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China

6. Editorial Board Meetings

In 2025, JTGG held 2 Editorial Board meetings:

• 26 March 2025 - Full Editorial Board meeting on journal development and strategic planning
• 4 August 2025 - Meeting with China-based board members to review progress and discuss future improvements

Figure 9. Editorial Board Meetings in 2025

In addition, a series of individual virtual meetings with board members were conducted between August and September, gathering further feedback andconstructive suggestions.

Figure 10. Virtual Meeting with Editor Prof. Kun Xia and Chair of the Junior Editorial Board Dr. Wenzhao Wang

7. Expert Interviews

During 2025, JTGG conducted interviews with 9 researchers and clinicians in genetics and genomics, providing insights into current researchtrends and future directions in translational genomics.

Figure 11. Expert Interviews in 2025

8. Webinars

JTGG organized 6 academic webinars in 2025, focusing on hot topics in genetics and genomics. Each webinar attracted over 18,000 viewers, fostering knowledge exchange within the community

Figure 12. Academic Webinars in 2025

9. Author Workshops

In October 2025, JTGG hosted an in-person author workshop in Ganzhou, Jiangxi, China, as part of the 4th Synergene Lecture SeriesonAdvancing Competencies in Medical Genetics and Genomics. JTGG served as a partner journal for the event. For the first time, thesessionincluded an in-person dedicated workshop on Academic Integrity and International Manuscript Preparation. Supported by OAE PublishingInc. as part of its 10th Anniversary initiatives, the workshop aimed to help early-career researchers better understand scholarly standards andinternational publication practices.

Figure 13. JTGG Author Workshop at the 4th Synergene Lecture Series on Advancing Competencies in Medical Genetics and Genomics

10. Academic Conferences and Outreach

In 2025, JTGG representatives participated in 4 academic conferences, including the 2025 CACA (Chinese Anti-Cancer Association) TumorBiomarker Conference, the 7th China Conference on Innovation and Development in Biological Diagnostics, the 2025 National AcademicSymposium of the Genetics Society of China, and the 4th Synergene Lecture Series on Advancing Competencies in Medical Genetics andGenomics. During these events, the team actively engaged with researchers, promoted the journal, and learned about emerging researchdevelopments, supporting JTGG's visibility and fostering potential collaborations.

Figure 14. JTGG Editors at Academic Conferences in 2025

Additionally, 27 Editorial Board and Junior Editorial Board members promoted JTGG through 33 outreach activities, including conferencepresentations and institutional visits. Three of these activities were conducted by international board members, reflecting the journal's growingglobal engagement.

11. Conference Promotion Partnerships

JTGG established partnerships with 12 academic conferences in 2025, expanding its visibility among relevant research communities andstrengthening connections with scholars in translational genetics and genomics.

Figure 15. Logos of 2025 Partner Conferences

12. Publishing Partnerships with Academic Society

In 2025, JTGG became an affiliated journal of the Association of Chinese Geneticists in America (ACGA). This partnership strengthens thejournal's international outreach and encourages academic exchange among researchers working in genetics and genomics worldwide.

Figure 16. Logo of the Association of Chinese Geneticists in America

Acknowledgments

Overall, 2025 was a year of steady and constructive progress for JTGG. With enhanced editorial selectivity, broader international participation, increased citation activity, and improved indexing coverage, JTGG continues to develop as a dynamic platform for research in genetics andgenomics. We sincerely thank all Editorial Board members, guest editors, reviewers, authors, readers, and editorial staff for their dedicationand support throughout the year.

Looking ahead, the editorial team remains committed to strengthening editorial quality, expanding international collaboration, and supportingthe dissemination of research that advances translational genetics and genomics.

Editor: Yana Wei
Language Editor: Catherine Yang
Production Editor: Ting Xu
Respectfully Submitted by the Editorial Office of Journal of Translational Genetics and Genomics